Age-related differences hepatic drug clearance children studies lorazepam antipyrine disposition intravenous antipyrine lorazepam model substrates hepatic oxidative metabolism conjugation children mean age years range years acute lymphocytic leukemia complete remission group ten healthy adults Antipyrine clearance weight children adults versus ml/min/kg different surface area contrast lorazepam total clearance CL unbound clearance CLu weight different children adults children surface area CL versus CLu versus mean lorazepam fraction unbound children different adult volunteers study significant differences children adults disposition compounds milliliter minute clearance antipyrine lorazepam 